BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38140086)

  • 1. Bioanalysis of the Ex Vivo Labile PACE4 Inhibitory Peptide Ac-[d-Leu]LLLRVK-Amba in Whole Blood Using Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Quantification.
    Sauter M; Haag J; Bay C; Leuschner F; Haefeli WE; Kuhn TC; Burhenne J
    Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the Selectivity of PACE4 Inhibitors through Modifications of the P1 Residue.
    Dianati V; Navals P; Couture F; Desjardins R; Dame A; Kwiatkowska A; Day R; Dory YL
    J Med Chem; 2018 Dec; 61(24):11250-11260. PubMed ID: 30501188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation.
    Levesque C; Couture F; Kwiatkowska A; Desjardins R; Guérin B; Neugebauer WA; Day R
    Oncotarget; 2015 Feb; 6(6):3680-93. PubMed ID: 25682874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced anti-tumor activity of the Multi-Leu peptide PACE4 inhibitor transformed into an albumin-bound tumor-targeting prodrug.
    Kwiatkowska A; Couture F; Ait-Mohand S; Desjardins R; Dory YL; Guérin B; Day R
    Sci Rep; 2019 Feb; 9(1):2118. PubMed ID: 30765725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioanalysis of selinexor in mouse plasma micro-samples utilizing UPLC-MS/MS.
    Sauter M; Foerster KI; Benzel J; Pfister S; Pajtler KW; Haefeli WE; Burhenne J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Jun; 1176():122781. PubMed ID: 34051651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines.
    Dianati V; Kwiatkowska A; Couture F; Desjardins R; Dory YL; Day R
    J Med Chem; 2018 Sep; 61(18):8457-8467. PubMed ID: 30180568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations.
    Łepek T; Kwiatkowska A; Couture F; Ly K; Desjardins R; Dory Y; Prahl A; Day R
    Eur J Cell Biol; 2017 Aug; 96(5):476-485. PubMed ID: 28483279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First observation of N-acetyl leucine and N-acetyl isoleucine in diabetic patient hair and quantitative analysis by UPLC-ESI-MS/MS.
    Min JZ; Tomiyasu Y; Morotomi T; Jiang YZ; Li G; Shi Q; Yu HF; Inoue K; Todoroki K; Toyo'oka T
    Clin Chim Acta; 2015 Apr; 444():143-8. PubMed ID: 25687163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Leuprolide-Fatty Acid Conjugate in Rat Plasma Using LC-MS/MS and Its Pharmacokinetics after Subcutaneous Administration in Rats.
    Seong GS; Seo SW; Cho JY; Lee KW; Lee BJ; Yoon IS; Jin HE
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Highly sensitive determination of three kinds of amanitins in urine and plasma by ultra performance liquid chromatography-triple quadrupole mass spectrometry coupled with immunoaffinity column clean-up].
    Zhang X; Cai X; Zhang X; Li R; Zhao Y
    Se Pu; 2022 May; 40(5):443-451. PubMed ID: 35478003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of the species origin and thrombin-like enzyme content of
    Xian R; Hang B; Gong L; Wang C; Zhang X; Peng L; Shi F
    Se Pu; 2022 Sep; 40(9):810-816. PubMed ID: 36156627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    J Pharm Anal; 2020 Jun; 10(3):233-239. PubMed ID: 32612869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability Evaluation and Stabilization of a Gastrin-Releasing Peptide Receptor (GRPR) Targeting Imaging Pharmaceutical.
    Ghosh A; Woolum K; Kothandaraman S; Tweedle MF; Kumar K
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31398865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of triple quadrupole tandem mass spectrometry to the bioanalysis of collision-induced dissociation-resistant cyclic peptides - Ultra-sensitive quantification of the somatostatin-analog pasireotide utilizing UHPLC-MS/MS.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    J Pharm Biomed Anal; 2021 Feb; 194():113728. PubMed ID: 33234413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of fascaplysin in rat plasma with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS): application to a pharmacokinetic study.
    Hu Z; Zhang M; He M; Fang B; Bao X; Yan X; Liang H; Wang H
    J Pharm Biomed Anal; 2019 Jul; 171():126-131. PubMed ID: 30986762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing the Drug-Like Profile of a Potent Peptide PACE4 Inhibitor by the Formation of a Host-Guest Inclusion Complex with β-Cyclodextrin.
    Navals P; Kwiatkowska A; Mekdad N; Couture F; Desjardins R; Day R; Dory YL
    Mol Pharm; 2023 Sep; 20(9):4559-4573. PubMed ID: 37555521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive, wide-range and high-throughput quantification of cyclosporine in whole blood using ultra-performance liquid chromatography coupled to tandem mass spectrometry and comparison with an antibody-conjugated magnetic immunoassay.
    Watanabe T; Tanaka R; Ono H; Suzuki Y; Tatsuta R; Itoh H
    Biomed Chromatogr; 2021 Aug; 35(8):e5128. PubMed ID: 33780006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of an UHPLC-ESI-QTOF-MS method for quantification of the highly hydrophilic amyloid-β oligomer eliminating all-D-enantiomeric peptide RD2 in mouse plasma.
    Hupert M; Elfgen A; Schartmann E; Schemmert S; Buscher B; Kutzsche J; Willbold D; Santiago-Schübel B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():123-129. PubMed ID: 29248770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.
    Couture F; Levesque C; Dumulon-Perreault V; Ait-Mohand S; D'Anjou F; Day R; Guérin B
    Neoplasia; 2014 Aug; 16(8):634-43. PubMed ID: 25220591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro metabolism and pharmacokinetics of cholinesterase inhibitor deoxyvasicine from aerial parts of Peganum harmala Linn in rats via UPLC-ESI-QTOF-MS and UPLC-ESI-MS/MS.
    Deng G; Liu W; Ma C; Rong X; Zhang Y; Wang Y; Wu C; Cao N; Ding W; Guan H; Cheng X; Wang C
    J Ethnopharmacol; 2019 May; 236():288-301. PubMed ID: 30872168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.